Esperion Therapeutics, Inc. (ESPR)
NASDAQ: ESPR · Real-Time Price · USD
2.000
-0.030 (-1.48%)
At close: Nov 4, 2024, 4:00 PM
1.970
-0.030 (-1.50%)
Pre-market: Nov 5, 2024, 5:45 AM EST
Esperion Therapeutics Market Cap
Esperion Therapeutics has a market cap or net worth of $392.45 million as of November 5, 2024. Its market cap has increased by 346.98% in one year.
Market Cap
392.45M
Enterprise Value
472.28M
1-Year Change
346.98%
Ranking
Category
Stock Price
$2.00
Market Cap Chart
Since June 26, 2013, Esperion Therapeutics's market cap has increased from $204.10M to $392.45M, an increase of 92.28%. That is a compound annual growth rate of 5.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2024 | 392.40M | 15.41% |
| Dec 29, 2023 | 340.00M | -25.93% |
| Dec 30, 2022 | 459.00M | 215.68% |
| Dec 31, 2021 | 145.40M | -79.94% |
| Dec 31, 2020 | 724.80M | -55.52% |
| Dec 31, 2019 | 1.63B | 32.13% |
| Dec 31, 2018 | 1.23B | -28.50% |
| Dec 29, 2017 | 1.72B | 510.80% |
| Dec 30, 2016 | 282.40M | -43.67% |
| Dec 31, 2015 | 501.30M | -39.08% |
| Dec 31, 2014 | 822.90M | 290.00% |
| Dec 31, 2013 | 211.00M | 3.38% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GH Research | 424.03M |
| GRAIL | 420.72M |
| 4D Molecular Therapeutics | 420.69M |
| Theravance Biopharma | 405.07M |
| Tevogen Bio Holdings | 404.43M |
| C4 Therapeutics | 396.00M |
| enGene Holdings | 393.08M |
| Sangamo Therapeutics | 391.45M |